Policy
White House-EMD Serono IVF Deal Signals Regulatory Shift for Fertility Industry
White House-EMD Serono IVF deal cuts drug costs 84%. Analysis of competitive impacts, clinic valuation risks, and regulatory implications for fertility investors.
Policy
White House-EMD Serono IVF deal cuts drug costs 84%. Analysis of competitive impacts, clinic valuation risks, and regulatory implications for fertility investors.
Fertility Care Business